2018 Third quarter
We will announce our 2018 third quarter results on Wednesday 31 October. Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Simon Dingemans, CFO; Luke Miels, President, Global Pharmaceuticals; and David Redfern, Chief Strategy Officer at 14:30 GMT, 10:30 EDT.
2018 Second quarter and R&D update
We announced our second quarter 2018 results on Wednesday 25 July and hosted an investor event where Emma Walmsley, CEO, and Simon Dingemans, CFO, spoke about our performance and financial outlook, and Hal Barron, Chief Scientific Officer and President, R&D, presented our R&D update.
- Q2 2018 results and R&D update announcement PDF - 1.0MB
- Q2 2018 slides - Emma Walmsley PDF - 495.7KB
- Q2 2018 slides - Simon Dingemans PDF - 131.7KB
- R&D update slides - Hal Barron PDF - 1.9MB
- Q2 2018 results transcript - Part 1 PDF - 188.4KB
- Q2 2018 results transcript - Part 2 PDF - 242.3KB
- Q2 2018 results infographic PDF - 556.7KB
- Q2 2018 US dollar translation PDF - 131.6KB
- Q2 2018 pre announcement aide memoire PDF - 742.2KB
2018 First quarter
We announced our first quarter 2018 results on Wednesday 25 April.
2017 Full year and fourth quarter
We announced our full year and fourth quarter 2017 results on Wednesday 7 February.
2017 Third quarter
We announced our third quarter 2017 results on Wednesday 25 October.
Other key information
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Keep up to date with our news and recent announcements
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business